Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.
Clinical trial NCT04851535 · COMPLETED
Trial details
- NCT number
- NCT04851535
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2022-11-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.